These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27297691)

  • 1. Prochelator strategies for site-selective activation of metal chelators.
    Oliveri V; Vecchio G
    J Inorg Biochem; 2016 Sep; 162():31-43. PubMed ID: 27297691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulus-Responsive Prochelators for Manipulating Cellular Metals.
    Wang Q; Franz KJ
    Acc Chem Res; 2016 Nov; 49(11):2468-2477. PubMed ID: 27749047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
    Giampietro R; Spinelli F; Contino M; Colabufo NA
    Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of copper and iron homeostasis by metal chelators: a possible chemotherapy for Alzheimer's disease.
    Robert A; Liu Y; Nguyen M; Meunier B
    Acc Chem Res; 2015 May; 48(5):1332-9. PubMed ID: 25946460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardioprotective Potential of Iron Chelators and Prochelators.
    Jansová H; Šimůnek T
    Curr Med Chem; 2019; 26(2):288-301. PubMed ID: 28933303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prochelators triggered by hydrogen peroxide provide hexadentate iron coordination to impede oxidative stress.
    Leed MG; Wolkow N; Pham DM; Daniel CL; Dunaief JL; Franz KJ
    J Inorg Biochem; 2011 Sep; 105(9):1161-72. PubMed ID: 21708101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chelating mitochondrial iron and copper: Recipes, pitfalls and promise.
    Lamačová LJ; Trnka J
    Mitochondrion; 2024 Sep; 78():101903. PubMed ID: 38777220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different approaches to the study of chelating agents for iron and aluminium overload pathologies.
    Crisponi G; Dean A; Di Marco V; Lachowicz JI; Nurchi VM; Remelli M; Tapparo A
    Anal Bioanal Chem; 2013 Jan; 405(2-3):585-601. PubMed ID: 23096940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron: effect of overload and deficiency.
    Hider RC; Kong X
    Met Ions Life Sci; 2013; 13():229-94. PubMed ID: 24470094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes.
    Deraeve C; Pitie M; Meunier B
    J Inorg Biochem; 2006 Dec; 100(12):2117-26. PubMed ID: 17011628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of iron chelation in free radical-induced oxidative stress and human disease.
    Jomova K; Valko M
    Curr Pharm Des; 2011; 17(31):3460-73. PubMed ID: 21902663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective-neurorestorative moieties for Alzheimer's therapy.
    Zheng H; Youdim MB; Fridkin M
    J Med Chem; 2009 Jul; 52(14):4095-8. PubMed ID: 19485411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
    Lanza V; Milardi D; Di Natale G; Pappalardo G
    Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metal ions, Alzheimer's disease and chelation therapy.
    Budimir A
    Acta Pharm; 2011 Mar; 61(1):1-14. PubMed ID: 21406339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reorganizing metals: the use of chelating compounds as potential therapies for metal-related neurodegenerative disease.
    Badrick AC; Jones CE
    Curr Top Med Chem; 2011; 11(5):543-52. PubMed ID: 21189128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DFT investigation on the selective complexation of Fe
    Kaviani S; Izadyar M; Housaindokht MR
    J Mol Graph Model; 2018 Mar; 80():182-189. PubMed ID: 29414037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
    Thiele NA; Abboud KA; Sloan KB
    Eur J Med Chem; 2016 Aug; 118():193-207. PubMed ID: 27128183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential application of iron chelators for the treatment of neurodegenerative diseases.
    Hider RC; Roy S; Ma YM; Le Kong X; Preston J
    Metallomics; 2011 Mar; 3(3):239-49. PubMed ID: 21344071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chelating agents for neurodegenerative diseases.
    Ward RJ; Dexter DT; Crichton RR
    Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.